LIZETH CUEVAS SOTO: Open Payments
NPI 1922866680 · YUMA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 28 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $249 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $188 |
| Lilly USA, LLC | 5 | $83 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Averitas Pharma Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
Products named: UBRELVY, MOUNJARO, QULIPTA, AIRSUPRA, VARIVAX, QUTENZA, JARDIANCE, Ozempic.
Industry payments across AZ — which companies pay providers there.
